| 摘要 |
FIELD: medicine.SUBSTANCE: group of inventions relates to medicine and is intended for treating hyperproliferation diseases and increasing bioavailability of preparation for hyperproliferation disease treating. Patients receiving simultaneously acidity reducing agents, such as proton pump inhibitors, and PI3K inhibitor, compound GDC-0941, on this therapy background preparations for repeated acidification are prescribed.EFFECT: group of inventions allows improving of GDC-0941 bioavailability.10 cl, 10 dwg, 1 tbl, 7 ex |
